SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-004066
Filing Date
2019-03-28
Accepted
2019-03-28 07:01:32
Documents
82
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 form20-f.htm 20-F 2968306
2 img_001.jpg GRAPHIC 41319
3 img_002.jpg GRAPHIC 32168
4 img_003.jpg GRAPHIC 11253
5 img_004.jpg GRAPHIC 1906
6 ex12-1.htm EX-12.1 16222
7 ex12-2.htm EX-12.2 15532
8 ex13-1.htm EX-13.1 11028
9 ex15-1.htm EX-15.1 4925
  Complete submission text file 0001493152-19-004066.txt   8059793

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE FILE vblt-20181231.xml EX-101.INS 1444299
11 XBRL SCHEMA FILE vblt-20181231.xsd EX-101.SCH 63577
12 XBRL CALCULATION FILE vblt-20181231_cal.xml EX-101.CAL 53487
13 XBRL DEFINITION FILE vblt-20181231_def.xml EX-101.DEF 208078
14 XBRL LABEL FILE vblt-20181231_lab.xml EX-101.LAB 400323
15 XBRL PRESENTATION FILE vblt-20181231_pre.xml EX-101.PRE 321628
Mailing Address HASATAT 8 ST. MODI'IN, L3 7178106
Business Address HASATAT 8 ST. MODI'IN, L3 7178106 972-3-6346450
Vascular Biogenics Ltd. (Filer) CIK: 0001603207 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-36581 | Film No.: 19709927
SIC: 2834 Pharmaceutical Preparations